Clinical Trial Update: HIV PrEP Priming of Immune Effectors [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update exploring HIV PrEP priming of immune effectors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-1 Infections

Snippet

Sponsor: MRC/UVRI and LSHTM Uganda Research Unit | Conditions: HIV-1 Infections | Phase 4 | Status: UNKNOWN